Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
80 participants
OBSERVATIONAL
2022-04-01
2027-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will invite participants aged 2-18 years, who the medical team suspect of having a PDOC, from various medical facilities in the UK, Ireland and other English-speaking countries. Parental/carer consent will be required for inclusion in the study.
Data collection will occur over 3 years. Each participant will be involved once for a maximum of 7 assessment sessions (4 for the MuSICCA, 1 for the Coma Recovery Scale - Revised (CRS-R), 1 for the Coma/Near Coma Scale (CNC), and 1 for the Nociception Coma Scale Revised (NCS-R)). The MuSICCA assessment protocol involves presenting musical stimuli in three modalities (visual, auditory, and tactile). The participants will be instructed to respond to stimuli and commands. Sessions will be recorded using audio-visual equipment and physical responses will be noted on documentation. The information gained will inform diagnosis and treatment. The participants' behaviours will also be scored on the CRS-R (the gold standard for diagnosis of DOC in adults), the CNC and the NCS-R.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Describing the Effect of Familiar Song on Arousal and Awareness for Children With Disorders of Consciousness (DoC)
NCT07209657
Efficacy of Music on Reduction of Sedative Drugs in Mechanically Ventilated Intensive Care Unit Patients
NCT00880035
Effectiveness of Music Therapy on Level of Consciousness
NCT04442971
Music Intervention and Transcranial Electrical Stimulation for Neurological Diseases
NCT05706831
Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps
NCT01459692
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The MuSICCA is not a valid tool for use with children and young people with Disorders Of Consciousness (DOC).
The MuSICCA is not a reliable tool for use with children and young people with DOC.
The MuSICCA is not a clinical useful tool for use with children and young people with DOC.
The design has been chosen to test the validity and reliability of the MuSICCA. It will involve carrying out the two measures and comparing their results against the current gold standard (the Coma Recovery Scale-Revised) and the Coma-Near Coma Scale. The design is influenced by previous validation studies of these measures conducted with adults.
There will be no control group because this is not a Randomised Controlled Trial (RCT) and, therefore, no recruited participant will be deprived of the potential benefits of the measures. All participants will receive intervention through the administration of the protocols of the assessment measures.
The study intends to recruit 80 participants. Recruitment will involve the following procedure. Medical/clinical teams at each site will identify potential participants according to the inclusion and exclusion criteria. The participants' families will be contacted to invite them to a meeting to discuss the research. It will be made clear that there will be no obligation to attend the meeting and their care or treatment will not be reduced or withdrawn if they decide not to be involved in the study. Interested families will be informed about the research project at this initial meeting. This information will be delivered verbally in person by the assessing clinicians and the families will be given a participant information sheet, which will contain all the information about the research so that the family can think in their own time about the decision to involve their child. The information given will include: 1)what will be carried out during the assessments, 2)how data will be recorded (observation recording sheets, video recording), 3)how the data will be stored, 4)what the data will be used for, and 5)what will be done with the data when the study has finished. The information sheet will also contain information about the families' right to withdraw their child from the study at any time without consequence.
The families will also be given the opportunity to ask questions so that they are satisfied that they understand why the research is being conducted, what the research will involve, and the extent of their child's involvement in the study if recruited.
Data collection will take place over a 3-year period at sites in the United Kingdom (UK), United States, and other English-speaking countries, e.g. Australia, Canada and New Zealand.
The data will consist of hand scored forms of the assessment tools and audio-visual recordings of the MuSICCA sessions. These recordings will be used to test the reliability of the MuSICCA between assessors and between assessment sessions.The selection and allocation of video recordings of sessions for inter-rater reliability will be carried out to control for differences of experience between assessing clinicians.
In order to eliminate researcher bias, data will be collated by the trained assessors from the treating clinical team, and statistical analysis will be undertaken by an independent statistician. In order to eliminate bias during data collection, there will be no interim data analysis and data collectors (clinicians) will not be able to discuss with each other the findings of their assessments until after the assessments have been completed and the results submitted to the research assistant.
Clinical utility of the MuSICCA will be evaluated using a questionnaire for each family and each assessing clinician using the tool. After each MuSICCA report is submitted and feedback given to the families, assessing clinicians and families will be asked to complete a short questionnaire to assess the clinical utility of the MuSICCA.
Data storage Raw data (score forms and video recordings) will be stored on a secure cloud-based system. Access to the data will be managed and authorised by the Chief Investigator.
Data analysis will be carried out by an independent statistician.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Assessed by the interdisciplinary team as having a disorder of consciousness
* Be under active investigation for diagnosis of DOC
Exclusion Criteria
* Known profound visual impairments
* Known musicogenic epilepsy
* Seizure disorders that cause frequent and/or prolonged seizures
* English not first language
2 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Temple University
OTHER
The Children's Trust, United Kingdom
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan W Pool, PhD
Role: STUDY_DIRECTOR
Anglia Ruskin University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Bethany Children's Health Centre
Bethany, Oklahoma, United States
The Children's Trust
Tadworth, Surrey, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Pool JW, Siegert RJ, Taylor S, Dunford C, Magee W. Evaluating the validity, reliability and clinical utility of the Music therapy Sensory Instrument for Cognition, Consciousness and Awareness (MuSICCA): protocol of a validation study. BMJ Open. 2020 Aug 13;10(8):e039713. doi: 10.1136/bmjopen-2020-039713.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
167534
Identifier Type: OTHER
Identifier Source: secondary_id
TCT 021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.